Kraig Biocraft Laboratories Is Testing Its Big Red™ Genetically Engineered Spider Silk
LANSING, Mich., April 22, 2014— Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of advanced spider silk based fibers, today announced that the Company received its fiber testing equipment, including customized components, to test its latest genetically engineered prototype fiber, Big Red™.
The Company announced that it created Big Red™, a new genetically engineered silk fiber, last fall, by using spider silk gene sequences. Preliminary testing indicated that Big Red™ might have properties of strength and flexibility that could have potential commercial applications.
The Company ordered testing equipment to verify the preliminary results and, after taking delivery, had the equipment customized to account for the unique nature of recombinant spider silk based fibers.
“We are excited to perform a more rigorous evaluation of Big Red™ spider silk with the new equipment. We are hopeful of having definitive test results within the next several weeks. So far, we are seeing a lot of variability, which may be an indication of genetic variation within the transgenic colony. Not only will these tests provide us the first comprehensive set of data concerning Big Red™, and potently guide us in improving that transgenic, but it’s also the first major assessment of the new equipment,” said Company founder and CEO, Kim Thompson.
The Company intends to use the testing equipment to increase the laboratory’s research and development effectiveness by providing researchers with more rapid feedback on the results of their work. The ability to quickly gather and analyze data is expected to greatly improve the effectiveness of the Company’s ongoing work in artificial selection of various strains of transgenic silkworms and potentially reduce the commercialization timeline for future fibers.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company, is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC.